Purdue Pharma

Stories 1 - 20 |  Next >>

Overlooked Player in Opioid Epidemic: The 'Middlemen'

New York Times investigation details the largely overlooked role of pharmacy benefit managers

(Newser) - When making a list of the main culprits in the nation's opioid epidemic, drugmakers and greedy doctors quickly come to mind. But a New York Times investigation looks at another group whose crucial efforts "have largely escaped notice"—pharmacy benefit managers. The name sounds innocuous, but PBMs...

McKinsey 'Deeply Sorry' for Helping Drugmaker Push Oxy

Consulting firm to pay $650M in settlement after assisting with Purdue Pharma's opioids push

(Newser) - The McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive drug OxyContin, per court papers filed in Virginia on Friday. The AP reports that, as part of...

Supreme Court Tosses Controversial Opioid Settlement

5-4 ruling blocks nationwide deal with Purdue Pharma over opioid epidemic

(Newser) - The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic. After deliberating...

McKinsey Settles Opioid Claims
McKinsey Settles Opioid Claims
Dec 30, 2023 1:25 PM CST

McKinsey Settles Opioid Claims

Consulting firm collaborated with Purdue Pharma, insurers say

(Newser) - Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its work with drug companies helped fuel an opioid addiction crisis. The agreement was revealed late Friday in documents filed in federal court in San Francisco. The settlement must...

It's a Big Day in Court for the Sackler Family

Supreme Court to consider whether Purdue Pharma owners should be shielded from opioid lawsuits

(Newser) - The nation's opioid crisis takes center stage at the Supreme Court on Monday, though the case in question centers mostly on an obscure part of bankruptcy law. The justices will hear arguments on whether members of the billionaire Sackler family, owners of OxyContin maker Purdue Pharma, should be shielded...

Supreme Court Freezes Deal That Protects Sackler Family

Justices agree to hear arguments on bankrupty deal that shields Sacklers

(Newser) - The Supreme Court on Thursday temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. The justices agreed to a request from the Biden administration to put the brakes on...

Victims Deal With Emotions After Facing Sacklers

Purdue owners had to sit through family statements

(Newser) - After telling the Sacklers how they and family members had suffered from or lost relatives to opioid addiction, some of the roughly two dozen people who made court statements Thursday were left to deal with the emotions and assess the value of the confrontations. Some who spoke emerged exhausted, others...

Victim to Sacklers: 'I Hope Every Face Haunts You'

Hearing was part of the Purdue Pharma settlement

(Newser) - Richard, Theresa, and David Sackler were forced to sit in silence Thursday as victims of the opioid epidemic told the owners of Purdue Pharma the damage Oxycontin had done to their lives and families. The session was mandated by the settlement that ended years of court fights, giving victims their...

OxyContin Settlement Includes a Statement of 'Regret'

Sacklers stop short of an unequivocal apology in opioid deal

(Newser) - Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion in a deal intended to staunch a flood of lawsuits facing the maker of OxyContin. The deal...

Sacklers Up Opioid Settlement, With an Unpopular Condition

Family behind Purdue Pharma wants protection from future lawsuits, as well

(Newser) - The family behind Purdue Pharma is willing to contribute another $1 billion to settle thousands of opioid crisis lawsuits, provided it buys the Sacklers immunity from all current and future civil cases. That protection was included in the first bankruptcy plan for the company, which was rejected last year by...

Judge Rejects Purdue Pharma Settlement

But the issue will likely go to an appeals court

(Newser) - A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the Sackler family from facing litigation of their own, the AP reports. US District Judge Colleen McMahon in New York found...

Judge Approves Settlement That Shields Sacklers

Purdue Pharma owners will be protected from future lawsuits over opioids

(Newser) - A federal bankruptcy judge gave conditional approval Wednesday to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. Under the settlement, the Sackler...

Purdue Pharma Heir Makes a Big Demand

He says Sackler family won't settle unless they are freed from opioid lawsuits

(Newser) - Members of the family that owns OxyContin maker Purdue Pharma won’t contribute billions of dollars to a legal settlement unless they get off the hook for all current and future lawsuits over the company’s activities, one of them told a court Tuesday in a rare public appearance. David...

Many Have Lukewarm Reaction to OxyContin Maker's Offer

$10B plan calls for turning the pharmaceutical giant into a new company

(Newser) - Some state attorneys general and opioid addiction activists pushed back Tuesday against a settlement offer from OxyContin maker Purdue Pharma, saying it didn't include enough money and goes too far in protecting the company and family members who own it from future liability. A group of nearly half the...

Sacklers Infuriate Lawmakers
Sacklers Infuriate Lawmakers
Dec 17, 2020 4:38 PM CST

Sacklers Infuriate Lawmakers

Family behind Purdue Pharma has no regrets over opioid crisis

(Newser) - The opioid epidemic has killed more than 400,000 Americans, according to the Centers for Disease Control and Prevention. Prescription opioids including Oxycontin, which Purdue Pharma put on the market about 25 years ago, caused about 230,000 of the deaths. The company's marketing pitched the pills to doctors...

OxyContin Maker Pleads Guilty to 3 Criminal Charges

Company admits role in opioid epidemic

(Newser) - Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally taking responsibility for its part in an opioid epidemic that has contributed to hundreds of thousands of deaths but also angering critics who want to see individuals held accountable, in addition to the company. In a virtual hearing with a...

Inside Purdue Pharma's $8B Settlement With the Feds
It Makes OxyContin. Now It's
Made a Deal With the Feds
the rundown
Oct 21, 2020 12:20 PM CDT

It Makes OxyContin. Now It's Made a Deal With the Feds

Inside the $8.3B Purdue Pharma settlement

(Newser) - OxyContin maker Purdue Pharma will plead guilty to three federal criminal charges, the Justice Department said Wednesday in announcing an $8.3 billion deal that settles the federal investigation of how the company marketed opioids, Politico reports. Those charges include conspiracy to defraud the US and violating federal anti-kickback laws....

Sacklers Withdrew Billions Amid Opioid Scrutiny

Audit raises new questions about whether $3B settlement offer by Purdue Pharma is enough

(Newser) - A new audit related to the Sackler family's vast wealth shows that family members withdrew more than $10 billion from their pharmaceutical company as the scope of the nation's opioid crisis became clearer, reports the New York Times . The AP notes this contrast: From 1995 through 2007, the...

Purdue Affiliate Accused of Selling 'Deeply Cynical' Drug

Or is Mundipharma selling a much-needed cure?

(Newser) - As Purdue Pharma buckles under a mountain of litigation and public protest in the United States, its foreign affiliate, Mundipharma, has expanded abroad, using some of the same tactics to sell the addictive opioids that made its owners, the Sackler family, among the richest in the world. Mundipharma is...

Victims Weren't in the Room When Opioid Maker Settled

But now 4 of them will play a role in Purdue Pharma's bankruptcy

(Newser) - Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic, the AP reports. Now that Purdue is in federal bankruptcy court, four people whose lives were touched...

Stories 1 - 20 |  Next >>